ReviewJournal of personalized medicine2021

From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1-Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific?

Lishi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.